New Study Presented at Alzheimer’s Association International Conference 2017 (AAIC) Validates Equivalency of Pen-and-Paper Cognitive Assessment (SAGE) with its Digital Counterpart (eSAGE) to Detect Mild Cognitive Impairment and Early Dementias

World News: . []

LONDON, July 17, 2017 (GLOBE NEWSWIRE) -- BrainTest Inc., a medical software company that provides scientifically validated cognitive screening instruments on a wide range of tablets and mobile devices, today announced that that the results of its Validity/Equivalency Study were presented at the Alzheimer’s Association International Conference 2017 (AAIC).

Data presented by Dr. Douglas W. Scharre, Professor of Clinical Neurology and Psychiatry at The Ohio State University Wexner Medical Center demonstrates eSAGE performs similarly with neuropsychological batteries, MoCA, and MMSE and shows no scale bias compared to the validated SAGE. Meaning eSAGE has a high sensitivity (71%) and specificity (90%) in detecting cognitive impairment from normal subjects, with the added advantage of private at-home self-administration.  Dr. Scharre’s results and data presentation will be available for the remainder of the AAIC at Location S8, P1-304.

Michael Kader
Tel: +1-614-388-9550

More news and information about BrainTest Inc.

Published By:

Globe Newswire: 08:00 GMT Monday 17th July 2017

Published: .

Search for other references to "study" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers